Functional mechanism studies confirmed that KANK3 acts as a key tumor suppressor gene in prostate cancer, and its expression silencing is closely associated with tumor aggressive phenotypes and PARP inhibitor resistance. This evidence concerns the gene PARP1 and prostate cancer.